Cargill Receives Official Notification From FDA Supporting the Safety of Truvia(T...(fferty@rfbinder.comatalanta.rafferty@rfb...),Health
Navigation Links
Cargill Receives Official Notification From FDA Supporting the Safety of Truvia(TM) Rebiana
Date:12/17/2008
fferty@rfbinder.com>atalanta.rafferty@rfbinder.com
'/>"/>
| SOURCE Cargill Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. E. Coli Registry Expanded for Victims of E. Coli Poisoning from Cargill Ground Beef
2. Volunteer for National Suicide Prevention Agency Earns Cargill Award
3. Cargill Executive Joins Blue Cross Board of Trustees
4. ChromaDex Partners With Cargill to Provide Global Quality Control Methods and Standards for Sweet Components of Stevia
5. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
6. DaVita Receives Civil Complaint
7. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
8. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
9. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
10. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
11. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
Post Your Comments:
Breaking Medicine News(10 mins):Health News:New Report Finds That Three in Ten California Households Cannot Afford Basic Needs 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 2Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 3Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 4Health News:Ophthonix Launches iZon(R) SL(TM) Polarized Lenses 2Health News:Ophthonix Launches iZon(R) SL(TM) Polarized Lenses 3
[1] New Report Finds That Three in Ten California Households Cannot Afford Basic Needs[0] Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009[0] Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab[0] Shoppers Cautioned Against Poisoning With Holiday Gifts[0] Ophthonix Launches iZon(R) SL(TM) Polarized Lenses
Other Medicine News:Health News:Families Encouraged to Enjoy Healthy Kids Fest at the Blue Cross RiverRink January 11 2Health News:Long-Term Care Industry Braces for Implementation of MDS 3.0: HCPro Responds with MDSonlineCentral.com 2Health News:Growing Shortage of Gastroenterologists to Affect Screening Capacity for #2 Cancer Killer 2Health News:Growing Shortage of Gastroenterologists to Affect Screening Capacity for #2 Cancer Killer 3Health News:Growing Shortage of Gastroenterologists to Affect Screening Capacity for #2 Cancer Killer 4Health News:Growing Shortage of Gastroenterologists to Affect Screening Capacity for #2 Cancer Killer 5Health News:Sun Pharmaceutical Extends Tender Offer for Taro 2Health News:Sun Pharmaceutical Extends Tender Offer for Taro 3Health News:ValueOptions(R) Enters Agreement with CareIntegra to Provide Integrated Health Services 2Health News:CEL-SCI Launches Study to Determine Long Lasting Beneficial Effects of its Rheumatoid Arthritis Vaccine 2Health News:CEL-SCI Launches Study to Determine Long Lasting Beneficial Effects of its Rheumatoid Arthritis Vaccine 3
Families Encouraged to Enjoy Healthy Kids Fest at the Blue Cross RiverRink January 11Long-Term Care Industry Braces for Implementation of MDS 3.0: HCPro Responds with MDSonlineCentral.comGrowing Shortage of Gastroenterologists to Affect Screening Capacity for #2 Cancer KillerSun Pharmaceutical Extends Tender Offer for TaroValueOptions(R) Enters Agreement with CareIntegra to Provide Integrated Health ServicesCEL-SCI Launches Study to Determine Long Lasting Beneficial Effects of its Rheumatoid Arthritis Vaccine
Breaking Medicine Technology:Giant Eagle(R) Pharmacy Receives Award for Operational Excellence 2Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 2Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 3Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 4Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 5Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 2Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 3Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 4Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 5Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 6Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 7Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 8Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 9Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 1Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 2Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 3Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 4Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 5Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 1Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 2Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 3Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 4Teens less likely to wash hands when cooking more likely to cross contaminate raw food than adults 61136 1Teens less likely to wash hands when cooking more likely to cross contaminate raw food than adults 61136 2
Other Medicine Technology:New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 2New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 3New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 4New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 5New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 6New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder 7Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 2Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 3Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |